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Objectives: To update the analysis of the cohort mortality and cancer incidence study of employees in the
Australian petroleum industry.
Methods: Employees of Australian Institute of Petroleum member companies were enrolled in the cohort in
four industry-wide surveys between 1981 and 1999. Mortality of 16 547 males and 1356 females was
determined up to 31 December 2001 and cancer incidence to 31 December 2000. Cause specific
mortality and cancer incidence were compared with those of the Australian population by means of
standardised mortality ratios (SMRs) and standardised incidence ratios (SIRs). Associations between
increased incidence of specific cancers and employment in the petroleum industry were tested by trends
according to period of first employment, duration of employment, latency, and hydrocarbon exposure,
adjusting for personal smoking history where appropriate.
Results: There was a significant elevation of the incidence of mesothelioma (SIR 1.77, 95% CI 1.05 to
2.79), melanoma (SIR 1.37, 95% CI 1.19 to 1.58), and prostate cancer (SIR 1.18, 95% CI 1.04 to 1.34).
The SIRs of all leukaemias and of acute non-lymphocytic leukaemia (ANLL) were not significantly different
from unity, but all 11 ANLL cases were clustered in the middle to high hydrocarbon exposure categories.
Tanker drivers had a significantly elevated incidence of kidney cancer (12 cases v 5.84 expected, SIR
2.05, 95% CI 1.06 to 3.59). Lung cancer incidence was significantly reduced (SIR 0.69, 95% CI 0.57 to
0.83)
Conclusions: Most cases of mesothelioma are probably related to past exposure to asbestos in refineries.
No occupational cause has been identified for the excess of melanoma, or prostatic or bladder cancer. The
possibility of a causal relationship between cancer of the kidney and hydrocarbon exposure warrants
further study. It is uncertain whether benzene exposures, particularly past levels of exposure, have been
high enough to cause ANLL.
T
he Australian Petroleum industry surveillance pro-
gramme Health Watch was established in 1980. The
cohort remained open to new entrants into the industry
until 2000, but has now been closed. The most recent analysis
of mortality and cancer incidence in the cohort included
deaths and cancers registered up to 31 December 1996.1 A
nested case-control study has also been conducted of the
association between leukaemia incidence and benzene
exposure.2 This update covers deaths up to 31 December
2001 and cancers registered up to 31 December 2000.
METHODS
Employees of Australian Institute of Petroleum member
companies were first enrolled in the cohort in 1980–83
through a survey interview. At interview, information was
obtained on work areas and tasks, and on smoking. Three
further surveys were carried out between 1985 and 2000 at
which new employees were enrolled and existing cohort
members still employed were re-interviewed. Head office
staff and those at facilities with fewer than 10 employees
were excluded. Interviewees were admitted to the cohort at
interview or on completion of five years of service, whichever
was the later. Participation was voluntary, and estimated
participation rates in the successive surveys were 92%, 92%,
84%, and 73%. Each year member companies provide
information on retirements, redundancies, and transfers.
Those no longer employed by member companies are
followed by periodic mailout to obtain an update of smoking
and other information.
Jobs are coded according to the system developed by the
American Petroleum Institute.3 4 Total hydrocarbon exposure
was derived from job codes, ranked by a committee of
industry occupational hygienists into seven categories of
exposure. Jobs not coded are assigned to the default category
4. It is a somewhat crude measure of exposure; a more
detailed, quantitative estimate of benzene exposures has been
undertaken as part of the nested case-control study of
leukaemia cases in the cohort.5
Deaths are identified by a search of the National Death
Index (NDI) maintained by the Australian Institute of Health
and Welfare (AIHW). Registered cancers in cohort members
are identified by a search of the National Cancer Statistics
Clearing House (NCSCH), a consolidated database from all
State and Territory cancer registries; it is searched for cancer
registrations maintained by the AIHW, except for cancers
registered in the States of Victoria and South Australia,
Table 1 State of the cohort as at 31 December 2001
Male Female
Died in Australia 1147 27
Still employed 4976 321
Retired from industry 10204* 935
Withdrawn` 220 73
Total 16547 1356
Person-years of follow up 242367 14906
Median employment duration (years) 18 10
Median year of birth 1947 1955
*Includes 23 emigrated and/or died overseas and 608 vital status
unknown.
Includes 3 emigrated and 124 vital status unknown.
`Employer quit Australian Institute of Petroleum in 1994.
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where the cancer registries conduct separate searches. Vital
status is also checked by periodic mailouts to subjects, and by
searches of the electoral roll and records of the Health
Insurance Commission (HIC).
Subjects’ follow up time commences on admission to the
cohort, which occurs on the date of initial survey interview or
on completion of five years of employment in the industry,
whichever is the later. Subjects lost to contact are censored
from the date of last contact.
Standardised mortality ratios (SMRs) and standardised
cancer incidence ratios (SIRs), adjusted by age and calendar
year of occurrence by five year groupings, were generated by
comparison of mortality and cancer incidence with national
rates. Exact 95% confidence intervals were calculated; these
do not rely on large numbers for validity.6 7 Tests for constant
SMRs and SIRs across several categories were carried out
using Poisson regression.8
Cancers with raised SIRs were analysed to detect trends in
relation to period of first employment and duration of
employment. To allow for uncertainties in latency, estimates
were made of variation in incidence with time since first
employment. Analyses were also performed for increasing
hydrocarbon rank score—both for the highest ranked job ever
held, and the rank score of the job held longest. The measure
of effect in these analyses was relative incidence ratios (RIR),
being the measure relative to a baseline stratum, adjusted by
age, calendar year, and, where appropriate, smoking. Poisson
regression was used for the relative incidence rate calcula-
tions using the method described by Berry9 and Breslow and
Day.10
The study was conducted with the approval of the Human
Research Ethics Committee of the University of Adelaide, and
the ethics committees of all State and Territory cancer registries.
RESULTS
The state of the cohort at 31 December 2001 is shown in
table 1. Although 3.6% and 9.1% of males and females
respectively were lost to contact as of 31 December 2001,
many of these had been found (e.g. in HIC files) relatively
recently, so that lost follow up time was only 1.3% in males
and 4.9% in females.
Mortality by major cause for both sexes is shown in table 2.
The all-cause SMR is significantly below unity in males. In
females the SMR was similarly lowered but statistical
significance is marginal. Mortality from all major causes in
males was significantly below unity. In females, 18 of the 27
deaths were from cancer but the cancer SMR was not
significantly raised. Mortality from heart disease was
significantly below unity (SMR 0.76, 95% CI 0.67 to 0.85).
Ischaemic heart disease mortality was strongly related to the
degree of tobacco use, with a more than fourfold increase in
those smoking more than 30 cigarettes per day. Mortality
from non-malignant respiratory disease, diseases of the
digestive system, and poisonings and violence were all
significantly less than unity (table 2).
Cancer mortality and cancer incidence in males are shown
in table 3. The SIR for all cancers was 1.02 (95% CI 0.96 to
1.08). There were significant excesses of the incidence of
mesothelioma (SIR 1.77, 95% CI 1.05 to 2.79), melanoma
(SIR 1.37, 95% CI 1.19 to 1.58), and prostate cancer (SIR 1.18,
95% CI 1.04 to 1.34). The incidence of lung cancer was
significantly below unity (SIR 0.69, 95% CI 0.57 to 0.83). The
all-cancer SMR was significantly less than unity (0.83, 95%
CI 0.76 to 0.91). There were no individual cancers for which
the SMR significantly exceeded unity, and only one cancer in
which the SMR was significantly less than unity, viz. lung
cancer (0.62, 95% CI 0.50 to 0.76).
Two of the 18 mesotheliomas were peritoneal; 15 of the 18
cases occurred in refinery workers.
Both lung cancer incidence and lung cancer mortality were
significantly reduced in comparison with the general male
population. Nevertheless lung cancer was the largest indivi-
dual cause of cancer mortality in the cohort (93 deaths).
There was a strong association between smoking and lung
cancer incidence. There was a 17-fold increase in risk in those
smoking up to 19 cigarettes per day compared with the risk in
those who have never smoked, a 22-fold increase in risk for
those who smoke 21–30 cigarettes per day, and a 43-fold
increase in risk for those who smoke more than 30 cigarettes
per day. Ex-smokers had a fivefold increase in risk. There
were only four lung cancers among lifelong non-smokers (4
per 77 507 person-years).
To test for a relative excess of lung cancer in refinery
maintenance workers, the incidence was compared with
refinery non-maintenance workers, with office workers
excluded. The incidence relative to non-maintenance workers,
after adjusting for smoking, was 1.10 (95% CI 0.47 to 2.64).
The incidence of melanoma was significantly raised overall,
and the excess was significantly increased in refinery and
terminal personnel. There was no significant association with
decade of hire, duration of employment, time since hire, or
hydrocarbon exposure ranking. Despite the excess incidence
the mortality rate from melanoma was not significantly
different from that of the general population (SMR 0.91, 95%
CI 0.55 to 1.53).
Prostatic cancer was the commonest cancer in males (251
cases), and the incidence was significantly elevated (SIR 1.18,
95% CI 1.04 to 1.34). There were only 35 deaths from
prostatic cancer, and the mortality rate was not significantly
different from that of the general population (SMR 0.94, 95%
CI 0.65 to 1.30). The incidence was raised in all categories of
workplace type except for airport personnel, but the excess is
not significant in any of them. There was no trend in
prostatic cancer incidence with period of first employment,
duration of employment, time since hire, or increasing rank
of hydrocarbon exposure.
Table 2 Mortality by major cause
Cause
Males Females
Obs/Exp SMR (95% CI) Obs/Exp SMR (95% CI)
Cancer (malignant) 459/553.1 0.83 (0.76–0.91) 18/17.5 1.03 (0.61–1.62)
Ischaemic heart disease 295/389.6 0.76 (0.67–0.85) 6/4.8 1.25 (0.46–2.72)
Stroke 50/79.8 0.63 (0.47–0.83) 0/2.2
Respiratory disease 79/99.8 0.79 (0.63–0.99) 1/2.3 0.43 (0.01–2.40)
Digestive system diseases 34/64.1 0.53 (0.37–0.74) 0/1.3
Accidents, violence, etc 100/153.9 0.65 (0.53–0.79) 0/3.1
All other causes 130/244.7 0.53 (0.44–0.63) 2/6.4 0.31 (0.04–1.14)
All causes 1147/1585.0 0.72 (0.68–0.77) 27/37.6 0.72 (0.47–1.04)
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There were 60 bladder cancers in males. Whereas the
previous update of this cohort showed a significant excess of
bladder cancer,1 in this analysis the incidence was not
significantly raised (SIR 1.17, 95% CI 0.89 to 1.50). There
were only nine deaths from bladder cancer, fewer than
expected on the basis of population rates, but the difference
is not statistically significant (SMR 0.81, 95% CI 0.37 to 1.53).
Bladder cancer did not occur in significant excess in any
workplace type, and there was no trend in incidence with
period of first employment, duration of employment, or time
since hire; nor was there any trend in incidence with
hydrocarbon exposure ranking. There were two bladder
cancers in women.
There were 34 leukaemia cases in males (SIR 1.07, 95% CI
0.74 to 1.49). In all individual leukaemia subtypes the rate
was close to the population rate except for acute lymphatic
leukaemia, where the SIR was 1.70 (95% CI 0.35 to 4.97)
based on only three cases. Mortality from leukaemia was
similar to the population rate (SMR 0.99, 95% CI 0.59 to
1.56).
There were 11 acute non-lymphocytic leukaemias (10.4
expected, SIR 1.06, 95% CI 0.53 to 1.90). Table 4 shows the
distribution of the 11 cases according to category of
hydrocarbon exposure. The cases were clustered in the
middle to upper level exposure categories; there were no
cases in the three lowest exposure categories in either table.
Table 5 shows the period of first employment of the ANLL
cases. Five of the 11 cases were first hired before 1955.
There was a small but statistically significant increase in
all-cancer incidence in drivers (SIR 1.15, 95% CI 1.00 to 1.32).
However, the only cancer in significant excess in drivers was
cancer of the kidney (12 cases v 5.84 expected, SIR 2.05, 95%
CI 1.06 to 3.59). Because there were only 12 cases, and since
all drivers are ranked in category 6 of hydrocarbon exposure,
it is not possible to conduct a meaningful analysis of trend
with hydrocarbon exposure. The SIR for cancer of the kidney
for the whole cohort was 1.15 (95% CI 0.84 to 1.54).
DISCUSSION
Participation in Health Watch is voluntary, but the high
participation rates, especially in the first two surveys (93%),
make volunteer bias very unlikely. The relatively low
participation rate in the fourth survey (estimated at 73%)
resulted in a lack of recruits to the cohort from offshore
Table 3 Cancer incidence and mortality in males
Cancer incidence Cancer mortality
Obs/Exp SIR (95% CI) Obs/Exp SMR (95% CI)
Lip, oral cavit,y and pharynx 55/73.0 0.75 (0.57–0.98) 8/19.3 0.41 (0.18–0.81)
Oesophagus 11/18.3 0.60 (0.30–1.08) 13/19.1 0.68 (0.36–1.16)
Stomach 35/35.9 0.97 (0.68–1.35) 19/22.9 0.83 (0.50–1.29)
Colorectal 186/179.8 1.03 (0.89–1.19) 63/74.8 0.84 (0.65–1.08)
Liver 8/12.2 0.66 (0.28–1.30) 10/12.9 0.78 (0.37–1.43)
Gallbladder 5/6.7 0.75 (0.24–1.75) 3/3.5 0.86 (0.18–2.51)
Pancreas 23/23.6 0.97 (0.62–1.46) 22/24.6 0.89 (0.56–1.35)
Larynx 18/20.9 0.86 (0.51–1.36) 6/8.0 0.75 (0.27–1.62)
Lung 113/163.8 0.69 (0.57–0.83) 93/149.0 0.62 (0.50–0.76)
Melanoma 191/139.0 1.37 (1.19–1.58) 19/20.8 0.91 (0.55–1.43)
Non-melanotic skin 3/5.7 0.52 (0.11–1.52)
Mesothelioma 18/10.2 1.77 (1.05–2.79)
Connective tissue 5/8.8 0.57 (0.18–1.32) 3/3.5 0.87 (0.18–2.53)
Prostate 251/212.5 1.18 (1.04–1.34) 35/37.3 0.94 (0.65–1.30)
Testis 19/14.3 1.33 (0.80–2.08) 1/1.0 1.01 (0.03–5.63)
Bladder 60/51.4 1.17 (0.89–1.50) 9/11.1 0.81 (0.37–1.53)
Kidney 45/39.1 1.15 (0.84–1.54) 14/14.7 0.95 (0.52–1.60)
Eye 5/4.0 1.24 (0.40–2.90)
Brain and nervous system 21/23.9 0.88 (0.54–1.34) 24/22.1 1.08 (0.70–1.61)
Non-Hodgkin’s lymphoma 48/54.0 0.89 (0.66–1.18) 22/22.2 0.99 (0.62–1.50)
Multiple myeloma 16/14.0 1.14 (0.65–1.85) 12/8.6 1.39 (0.72–2.42)
Leukaemia 34/31.9 1.07 (0.74–1.49) 18/18.2 0.99 (0.59–1.56)
Acute lymphatic leukaemia 3/1.8 1.70 (0.35–4.97) 2/1.6 1.24 (0.15–4.48)
Chronic lymphatic leukaemia 12/11.7 1.03 (0.53–1.79) 1/3.3 0.30 (0.01–1.67)
Acute myeloid leukaemia 8/8.3 0.97 (0.42–1.91) 6/8.2 0.73 (0.27–1.59)
Chronic myeloid leukaemia 5/4.6 1.09 (0.36–2.55) 4/2.8 1.45 (0.39–3.70)
Other leukaemia 6/5.6 1.07 (0.39–2.33) 5/2.3 2.21 (0.72–5.15)
Acute non-lymphocytic leukaemia 11/10.4 1.06 (0.53–1.90) 6/9.0 0.66 (0.24–1.45)
Other and unspecified sites 66/73.0 0.90 (0.70–1.15) 62/40.2 1.54 (1.18–1.98)
Total 1232/1210.5 1.02 (0.96–1.08) 459/553.1 0.83 (0.76–0.91)
Table 4 ANLL incident cases by total hydrocarbon (HC) exposure
Exposure category
Highest HC ranking job HC ranking longest job
Person-years Cases Person-years Cancer
1 41478 0 57030 0
2 20113 0 21560 0
3 2485 0 3721 0
4 104602 7 96148 7
5 8405 1 5997 1
6 36634 2 57030 3
7 13365 1 21560 0
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production, but did not significantly alter the composition of
the cohort: 4.0% of the cohort were in the offshore
production sector prior to the fourth survey, and 3.7% after it.
A potential weakness of the study is that subjects’ date of
hire is obtained from subjects at the time of interview.
Nevertheless any resulting error is likely to be random and
hence unlikely to lead to bias. Moreover errors from
imperfect recollection of the year of hire are likely to be
small in relation to the size of time related categories (e.g.
period of employment categories are pre-1954, 1955–64,
1965–74, and post-1975).
Identification of cancer is a strength of the study as cancer
registration is mandatory in all Australian States and
Territories, and registration is virtually complete. However,
complete matching cannot be guaranteed, and some missed
cases were identified when reconciling information from the
NCSCH with the state cancer registries which supply the
information to it. Seven cancers not found in the NCSCH
were excluded from the analysis, since for a valid comparison
of cancer incidence with the general population, cancer
registrations in the Health Watch cohort must also appear in
the NCSCH data (from which national cancer incidence
tables are derived).
The occurrence of 18 cases of mesothelioma is indicative of
asbestos exposure, and is consistent with the findings of
other studies in oil refinery workers.11–13 It is likely that some
of these cases are attributable to asbestos exposure prior to
entering the petroleum industry.
Although smoking prevalence in the cohort is similar to
that of the general population, the lung cancer rate is
significantly reduced. A possible explanation for the low lung
cancer incidence may be differences in the amount smoked,
i.e. smokers in the petroleum industry smoke less, and ex-
smokers quit sooner, than smokers in the general population;
lung cancer incidence is very sensitive to these variables.14
The relatively low incidence of lung cancer suggests that
there are few, if any, such cancers caused by asbestos.
Detailed analyses of asbestos related conditions will be given
in a separate paper.
Leukaemia has been a disease of special concern in this
industry because of its association with benzene exposure.
Although earlier analyses of this cohort showed an excess of
leukaemia incidence, subsequent updates have shown a
declining SMR, and there is now no significant excess of
leukaemias in the Health Watch cohort. Moreover, internal
analysis within the cohort shows no significant trend in
leukaemia incidence with duration of employment or with
increasing hydrocarbon exposure. This finding is not unex-
pected, since ‘‘leukaemia’’ is not a single disease, but a
composite of leukaemia types which are in fact different
disease entities. Acute non-lymphocytic leukaemia (ANLL) is
the only leukaemia subtype likely to be causally related to
benzene exposure.15
Overall there was no excess of ANLL (11 cases observed
and 10.35 expected). While this may suggest that benzene
exposures in this industry may be too low to cause a
detectable increase in the incidence of ANLL, it should be
noted that all 11 cases were clustered in the medium to
higher categories of hydrocarbon exposure; that is, there are
no cases at all in the three lowest exposure categories. It is
possible that the absence of any cases in the low exposure
categories could be due to errors in classification. The method
of exposure categorisation is a somewhat crude index of
exposure. Many tasks in the industry have not been assigned
an exposure category, and are assigned to the default
category 4 (out of 7), which is accordingly the largest
category in terms of follow up, and with the largest number
of leukaemia cases. Nevertheless the analyses of ANLL by
hydrocarbon exposure are similar to that of the Health Watch
case-control study, in which careful estimates of benzene
exposure were made.5 This suggests that misclassification
bias has not contributed significantly to the findings of the
internal analyses.
Other cohort studies in this industry have not found an
excess of mortality from ANLL.16 A Canadian cohort study
found a marginally significant excess mortality from ANLL,
but most of the excess was in office workers.17 A later update
of this cohort showed no increase in ANLL incidence or
mortality.18 In a case-control study of petroleum marketing
and distribution workers in the UK, the authors concluded
that there was some suggestion of a relation between
exposure to benzene and myeloid leukaemia, particularly
acute myeloid leukaemia.19 A case-control study nested
within the Canadian cohort in 1996 has shown no association
between increasing benzene exposure and risk of leukae-
mia.20 On the other hand the case-control study from the
Health Watch cohort has found a strong association with
increasing benzene exposure. Moreover the benzene exposure
levels in the Health Watch case-control studies were in general
lower than in the UK and Canadian studies.2 The findings of
the cohort study indicate that, at most, only a very small
number of workers in this industry have developed ANLL
from benzene exposure.
The significance of the excess melanoma incidence is not
clear, but no causal association with any exposure in the
workplace is apparent since there is no tendency for
increasing risk with increasing duration of employment,
and risk shows no relationship to hydrocarbon exposure.
Melanoma incidence is strongly affected by intensity of
medical surveillance. The low mortality rate (SMR 0.90, 95%
CI 0.50 to 1.48) is consistent with early recognition as the
cause of the raised incidence rate. However an analysis of
staging of melanomas in Health Watch subjects registered in
the NSW Cancer Registry showed that melanomas were not
being diagnosed at an earlier stage than melanomas in the
general NSW population. Some excesses of melanoma
mortality and incidence have been reported in this industry,
but no occupational cause is apparent.21–23 Apart from the
well established association with exposure to solar radiation,
melanoma has a tendency to occur in higher socioeconomic
groups.24 There is no reason to suspect either factor being of
special significance in this cohort, which has mostly excluded
senior management.
Similarly there is no evidence linking the excess of
prostatic cancer to any occupational factor.
Table 5 ANLL incidence by period of first employment, adjusted for age and calendar
period of follow up
Period of first employment Person-years Cancer RIR 95% CI
Post-1975 110369 4 1.00
1965–74 72615 2 0.28 0.05–1.71
1955–64 29932 0 – –
Pre-1955 14259 5 1.62 0.20–13.29
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Bladder cancer was found in significant excess in the
previous analysis, but in this analysis the excess was found to
be less and non-significant (SIR 1.17, 95% CI 0.89 to 1.50).
Bladder cancer mortality was not elevated. An increased risk
of bladder cancer mortality has not been noted in this
industry, and in the only other cancer incidence study in the
industry no excess of bladder cancers was found.18
Although the incidence of cancer of the kidney was not
raised in the cohort as a whole, the incidence was statistically
elevated in drivers. Since there were only 12 cases, mean-
ingful analyses of incidence by time related factors were not
possible, and analyses by hydrocarbon exposure ranking is
not possible because drivers are all given the same exposure
ranking (category 6). However in the cohort as a whole there
was a significant trend of increasing relative incidence rate of
kidney cancer with increasing hydrocarbon exposure rank-
ing, even though the incidence of kidney cancer was not
significantly elevated. In the whole cohort there was no trend
to increasing incidence with increasing employment time.
There is limited prior evidence to suggest a possible link
between kidney cancer and hydrocarbon exposure. A
population based case-control study published in 1989 found
a weak positive association between renal cell carcinoma and
hydrocarbon exposure was found in males only.25 Another
population based case-control study based on incident cases
in the Danish Cancer Registry found a twofold increase in
risk of renal cell carcinoma in workers occupationally
exposed to gasoline (odds ratio 2.1, 95% CI 1.1 to 4.1).26 In
a 1993 report of Canadian petroleum distribution workers
(which includes drivers), a non-significant excess mortality
from kidney cancer (SMR 135) was found. Those exposed to
hydrocarbons daily had a relative risk of mortality from
kidney cancer of 3.80, although the excess was not
statistically significant.27 In another study of UK distribution
workers, the SMR for kidney cancer in drivers was 141.
Fifteen of the 25 deaths were in drivers with more than 20
years’ service, but the excess was not statistically signifi-
cant.28 Other mortality studies in the petroleum industry have
not noted an increase in cancers of the kidney,22 and the only
other cohort study of cancer incidence in this industry found
no excess of kidney cancer.18 The possibility of an association
between cancer of the kidney and hydrocarbon exposure
warrants further study, particularly in future studies of
cancer incidence.
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